Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by alnovaon May 14, 2018 10:37pm

183 Views

Post# 28030335

RE: AWARENESS

If I'm not mistaking,the company has plenty of Investor Relations on the payroll. They need to do just that. Create awareness!! As far as a Nasdaq listing goes, I don't believe a .35 stock trading on the Canadian Venture Exchange even has a chance. The company mentions that they hope to somehow collaborate or partner with pharma or medtech. News of this is what I feel it will take to move the share price significantly higher. Updates on clinical trial are nice to see, but until positive results can be achieved, it is just that. A trial. This is my opinion only. Best of luck to all Sernova shareholders.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity